Aggrenox® (aspirin/extended-release dipyridamole) 25 mg/200 mg capsules
HOME >>
ABOUT AGGRENOX >>
TAKING SMART STEPS™ >>
MEDICATION REMINDERS >>
 
Do more to reduce the risk of a stroke recurrence.
You'll learn how to get the most from your partnership with your doctor and maintaining a healthy lifestyle.

As part of this program, you can look forward to:

• A 15-day FREE trial offer* of AGGRENOX
• Education about stroke and TIA (transient ischemic attack)
• Resources to help learn about reducing the risk of a stroke recurrence
• Tips on diet and exercise
• Tips on talking to and partnering with the doctor

* Limit of 30 capsules.
Just complete the brief questions below to join today.
Required Information *

First Name *   
Last Name *   
Address *   
City *   
State *   Zip Code * 
Date of Birth * 
 
Email *   
Phone   
  (e.g. 123-456-7890)   


The following information is not required, however it will help us to provide you with the most relevant information based on your responses.

Female
Male
Patient
Caregiver
TIA (transient ischemic attack)
Stroke
Fewer than 3 months ago
More than 3 months ago
AGGRENOX
Aspirin
Coumadin® (warfarin)
Other
Plavix® (clopidogrel)
I am not currently taking any medication
E-mail
Direct mail

The information you are about to provide is being collected by Boehringer Ingelheim Pharmaceuticals, Inc. so that we may advertise our products to you and provide you with information about them.

Boehringer Ingelheim Pharmaceuticals, Inc. respects your right to have personal and medical information kept confidential. Boehringer Ingelheim and companies working with Boehringer Ingelheim will use the information you provide, as well as information from redeemed coupons and/or vouchers we have provided you, which we receive from the pharmacy, to fulfill your request and to help develop products, services, and programs. It will not be shared with any other third parties (such as mailing lists).

Plavix® is a registered trademark of Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

Coumadin® is a registered trademark of Bristol-Myers Squibb Co.
IMPORTANT: To complete your registration in the takingsmartsteps™ progra, please check a box below.
  By checking here and clicking "Sign Up" below, you indicate that you agree to the above and want us to use the information you have provided to send you information and offers relating to TIA/Stroke and AGGRENOX from time to time.

  By checking here and clicking "Sign Up" below, you indicate that you agree to the above and allow us to use your information to advertise TIA/Stroke and other products to you. Boehringer Ingelheim may also provide you with useful materials and contact you about health-related topics.

If you do not check either box, you will NOT be enrolled in the takingsmartsteps™ program and we will only fill this one time request.

Need Help paying for AGGRENOX? Our patient assistance program may be able to help. Boehringer Ingelheim CARES FOUNDATION
Important Safety Information
Aggrenox® (aspirin/extended release dipyridamole) 25 mg/200 mg capsules, a prescription medication, is approved to reduce the risk of stroke in patients who have had a stroke or a TIA. AGGRENOX contains aspirin. Like aspirin, AGGRENOX should be avoided in the third trimester of pregnancy and should not be used in children or teenagers because of the risk of Reye's syndrome. Patients with a history of stomach ulcers should avoid using aspirin. Because AGGRENOX contains aspirin, the risk of bleeding is increased and it may take longer to stop bleeding. Patients who consume three or more alcoholic drinks every day should be aware of the bleeding risks involved with chronic, heavy alcohol use while taking aspirin. Headache and stomach discomfort are common AGGRENOX side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information.
 
Content intended for U.S. residents only.
Copyright © 2009, Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved.
Use of this Site subject to Terms of Use and Privacy Policy.

Terms of Use  |  Privacy Policy  |  Contact Us
AG64520